03/19/2026
🌿 Blog Highlight of today: Berberine Supports Kidney Health
For many patients with early CKD, the real driver of progression is metabolic dysfunction: insulin resistance, inflammation, dyslipidemia, and central weight gain.
Berberine activates AMPK, improves insulin sensitivity, lowers triglycerides and LDL, reduces inflammatory cytokines like TNF-α and IL-6, and even modulates the gut–kidney axis by reducing uremic toxins such as indoxyl sulfate.
But here is what makes this clinically important:
Berberine also interacts with major drug pathways (CYP3A4 and P-glycoprotein). It can amplify the effects of:
• Diabetes medications
• ACE inhibitors and ARBs
• Statins
• Anticoagulants
• Immunosuppressants
In kidney care, that means strategy matters.
When used thoughtfully and monitored properly, berberine may complement metabolic therapy and potentially reduce cardiovascular and renal risk. When used casually, it may create unintended interactions.
Have you ever considered metabolic botanical support in early CKD?
Or reviewed supplement–medication interactions in your kidney patients?
Let’s discuss 👇
Read more here: [https://inkidney.com/berberine-supports-kidney-health/]